My guest today is Tania de Jong, co-founder of Mind Medicine Australia. Tania and her husband, Peter, helped lead the push that, in 2023, made Australia the first country in the world to allow MDMA and psilocybin to be prescribed for psychiatric conditions. I wanted to understand how the hell they helped make that happen and what the rest of the world can learn from it.
Please enjoy!
This episode is brought to you by:
- ProLon science-backed Fasting Mimicking Diet that helps activate cellular renewal through fasting, while you still eat nourishing meals
- Momentous high-quality creatine for cognitive and muscular support
- AG1 all-in-one nutritional supplement
Additional podcast platforms
Listen to this episode on Apple Podcasts, Spotify, Overcast, Podcast Addict, Pocket Casts, Castbox, YouTube Music, Amazon Music, Audible, or on your favorite podcast platform.
Transcripts
Show Notes
Connect with Tania de Jong
Website | LinkedIn | Mind Medicine Australia
Timeline
- February 2, 2015: Michael Pollan publishes “The Trip Treatment” in The New Yorker, which is the article Tania credits with setting her journey in motion.
- March 21, 2015: Tim releases his James Fadiman interview, “The Psychedelic Explorer’s Guide” (#66). Its show notes link to “The Trip Treatment.”
- January 15, 2016: In 5-Bullet Friday, Tim announces support for Johns Hopkins’ psilocybin research and a personal commitment of at least $100,000 toward psychedelic research that year.
- 2016: Tania and Peter travel to the Netherlands for their first guided psilocybin experience. (Source)
- 2017–2019: UCSF conducts the psilocybin-assisted group-therapy study involving long-term AIDS survivors that Tim helped support. (Source)
- May 6, 2018: Michael Pollan joins Tim for “Exploring the New Science of Psychedelics” (#313), discussing his forthcoming book (How to Change Your Mind).
- May 15, 2018: Pollan’s How to Change Your Mind is published.
- February 13, 2019: Tania and Peter publicly launch Mind Medicine Australia. (Source)
- 2020–2022: MMA applies to reschedule MDMA and psilocybin, faces rejection, and submits new applications in March 2022. (Source)
- November 21, 2022: David Nutt presents to Australia’s medicines regulator, the TGA, supporting the case for therapeutic access. (Source)
- February 3, 2023: The TGA announces restricted prescribing access to MDMA for PTSD and psilocybin for treatment-resistant depression, effective July 1, 2023. (Source)
- January 2024: Patients begin receiving treatment under the new prescribing program. (Source)
Related Reading, Listening, and Viewing
- The Trip Treatment by Michael Pollan | The New Yorker
- Michael Pollan — Exploring The New Science of Psychedelics | The Tim Ferriss Show #313
- Tania de Jong: How Singing Together Changes the Brain | TEDxMelbourne
- Becoming Nobody (Documentary about Ram Dass)
- ‘Serious Concerns’ over TGA’s Decision Making on Landmark Psilocybin, MDMA Ruling | ABC News
- Change to Classification of Psilocybin and MDMA to Enable Prescribing by Authorised Psychiatrists | Therapeutic Goods Administration
- Psilocybin-Assisted Group Therapy for Demoralized Older Long-Term AIDS Survivor Men: An Open-Label Safety and Feasibility Pilot Study | eClinicalMedicine
- Dr. Gül Dölen on Rethinking Psychedelics, the Neurobiology of Beginner’s Mind, and the Master Key of Metaplasticity | The Tim Ferriss Show #667
- Rick Doblin — The Psychedelic Domino That Tips All Others | The Tim Ferriss Show #440
- Roland Griffiths — Facing Death, Meditation, Psychedelics, and Living a Life of Gratitude | The Tim Ferriss Show #641
Books
- Be Here Now by Ram Dass
- How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence by Michael Pollan
- Waking the Tiger: Healing Trauma by Peter A. Levine, with Ann Frederick
Organizations and Resources
- Patient Support Fund | Mind Medicine Australia
- Certificate in Psychedelic-Assisted Therapies | Mind Medicine Australia
- TGA Rescheduling Submissions and Resources | Mind Medicine Australia
- Multidisciplinary Association for Psychedelic Studies | MAPS
- Connecting Science and Human Well-Being | Usona Institute
- Internal Family Systems Institute | IFS Institute
- Australian Interventional Pharmacotherapy and Psychedelic-Assisted Psychotherapy Research Registry | Australian National University
People
- Archimedes
- Dave Asprey
- Robin Carhart-Harris
- Wade Davis
- Rick Doblin
- Gül Dölen
- Paul Fitzgerald
- Roland Griffiths
- Peter Hunt
- Aldous Huxley
- LeBron James
- John Krystal
- Timothy Leary
- Peter Levine
- Bill Linton
- Maharaj-ji
- Gabor Maté
- Richard Nixon
- David Nutt
- Michael Pollan
- Ram Dass
- Bill Richards
- Dick Schwartz
- Sasha Shulgin
- John Skerritt
- Bessel van der Kolk
- Andrew Weil
- Phil Wolfson
Timestamps
- [00:00:00] Intro from Tim.
- [00:02:46] The article that changed Tania’s life.
- [00:04:39] A first psychedelic experience—and the year it took to integrate it.
- [00:10:17] Rick Doblin’s encouragement and the birth of Mind Medicine Australia.
- [00:13:14] Turning regulatory rejection into a stronger application.
- [00:20:48] Building a grassroots movement and training clinicians.
- [00:23:23] Cold emails, scientific allies, and singing your way into the room.
- [00:31:11] A week with Ram Dass: silence, singing, and an extraordinary LSD story.
- [00:37:54] Bringing David Nutt—and a family’s devastating story—to the regulators.
- [00:42:42] Dancing in the kitchen: Australia’s rescheduling breakthrough.
- [00:43:40] From changing the rules to treating patients.
- [00:48:18] Why Tim thinks MDMA is still underestimated.
- [00:50:23] Integration beyond the session: therapy, nutrition, and exercise.
- [00:52:29] Scaling access and collecting real-world evidence.
- [00:58:13] Getting insurers, government agencies, and philanthropists on board.
- [01:00:41] Syrian rue, psilocybin, and learning to let go of control.
- [01:09:06] Dosing, expectations, and the pressure to take more.
- [01:11:07] The promise of group therapy and shared integration.
- [01:13:28] Hiring mistakes, personal attacks, and the resilience advocacy requires.
- [01:22:43] Turning a window of change into lasting habits.
- [01:24:56] Getting through to regulators and pushing for end-of-life access.
- [01:27:32] The bureaucratic barriers that remain.
- [01:30:43] What treatment costs—and why therapist time drives the bill.
- [01:34:12] Could shorter-acting compounds make treatment more affordable?
- [01:37:52] Ketamine, kratom, and the limits of “all natural.”
- [01:42:19] The unexpected payoff from Tim’s ketamine experiment.
- [01:46:52] What might come next for psychedelic access worldwide?
- [01:48:10] Persistence versus pushiness—and knowing when to try another door.
- [01:53:27] Supporting patients and training the next wave of clinicians.
- [01:56:56] “Be curious”: exploring your inner world and walking each other home.
- [02:00:40] The ripple effects of sharing your curiosity—and simply asking for help.
- [02:05:10] Parting thoughts.
Quotations from This Episode
“Be curious.”
— Tania de Jong
“I never saw a single piece of nature the same since that [first high-dose psilocybin session]. So every seashell, cloud, leaf, blade of grass, just everything was transformed by that experience, and I could see the energy in everything.”
— Tania de Jong
“We want people to have meaningful lives. We want them to feel healthy. We want them to be able to see the sacred in everything.”
— Tania de Jong
“When you’re trying to change the law, you need people around you that are very strong and who are resilient because we got knocked down over and over.”
— Tania de Jong
“You can sort of see that anyone who’s a pioneer who’s trying to drive change is going to be attacked.”
— Tania de Jong
“We all have to become our own chief medical officers. We have to work out what’s going to work for us, what’s going to make us whole and healed so that we can live our best lives possible.”
— Tania de Jong
“One of the great things I learned was to never let anyone snatch your dreams away.”
— Tania de Jong
“Let’s just keep asking questions and not outsourcing ourselves to all of the chatbots and all of the robots.”
— Tania de Jong
Want to hear another episode with someone who spent decades turning a stigmatized medicine into approved treatment? Listen to my conversation with MAPS founder Rick Doblin, in which we discussed the founding of MAPS, MDMA’s unlikely path from the lab into the therapy room, Sasha Shulgin, the difference between MDMA and MDA, MDMA-assisted psychotherapy for PTSD, treating veterans and first responders, what it cost to champion psychedelics long before the mainstream caught on, the fight to reschedule MDMA, a surprise $10M challenge, and much more.
This episode is brought to you by AG1. I’ve taken AG1 for more than a decade. Longtime listeners have heard me call it my nutritional insurance. Here’s the news: they recently launched AG1 Pro, designed for people focused on performance and longevity. I’ll be traveling soon, and I’m throwing this in my bag to cover my bases while I travel. Past a certain age, maintaining lean muscle becomes priority number one, and AG1 Pro is formulated to support exactly that. It includes HMB, a clinically studied compound that supports protein synthesis and helps reduce protein breakdown, plus zinc carnosine to support the gut lining. Remember: training is only half the equation. Recovery is where the work compounds, and AG1 Pro is built to support it. It’s NSF Certified for Sport, so what’s on the label is what’s in the pouch. Get your free AG1 Pro Yeti Shaker in the Welcome Kit at Drinkag1.com/Tim.
This episode is brought to you by Momentous Creatine! I’ve used Momentous Creatine for a long time, as it’s been one of the highest-quality creatine options available. Now, Momentous has taken that quality even further with Signature Spec Creatine, their most advanced version yet. Signature Spec is manufactured in a pharmaceutical facility using reverse-osmosis water purification. It’s verified through a six-stage testing process with four independent agencies—delivering 10x fewer impurities, 2–5x tighter heavy-metal limits, and added PFAS and microplastics screening.
The ultrafine powder also mixes cleanly, with no grit. Creatine supports strength, power, lean muscle, and recovery, with growing research on enhanced memory and cognitive performance. Head to LiveMomentous.com/Tim and use code TIM for 14% off your first one-time order or a total of 35% off your first subscription order.
This episode is brought to you buy ProLon! One name that has come up on this podcast more than once is Dr. Valter Longo, a USC professor with decades of peer-reviewed research on fasting, nutrition, and aging. I regularly fast and have done a lot of experiments with fasting over more than a decade, and it has been one of the most incredible unlocks that I have found for both near- and long-term physical and mental health.
But fasting can be really hard, and that is why Dr. Longo, best known for the Fasting Mimicking Diet (FMD), developed ProLon. For 5 days, you’re able to get the benefits of fasting—including autophagy, your body’s cellular, self cleanup process—all while eating real, structured, plant-based meals. In scientific studies, 5-day cycles of the Fasting Mimicking Diet improved markers tied to metabolic health and biological aging and helped people drop fat while holding onto lean muscle. And ProLon makes it easy: it comes in one box, everything is clearly laid out, and there’s no guesswork. For a limited time, Prolon is offering my listeners 15% off sitewide, plus a $40 bonus gift when you subscribe to their 5-day program. Just visit ProLonLife.com/Tim.


Comment Rules: Remember what Fonzie was like? Cool. That's how we're gonna be — cool. Critical is fine, but if you're rude, we'll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for adding to the conversation! (Thanks to Brian Oberkirch for the inspiration.)
Incredible story. Tania and Peter are changing the world and countless lives through Mind Medicine Australia. Thank you for what you do
Fascinating. 750 trained therapists is an incredible level of scale and impact. Well done, Tania. Thank you for sharing, Tim!
Thank you for this episode, Tim! I helped run a small psilocybin education and advocacy project in Iowa a few years ago, and my spouse and I hope to move to Australia someday, so this conversation meant a lot to me for multiple reasons. Tania's persistence through every rejection is so inspiring, and it gives me hope that regular citizens can still change things this big. Thank you Tim and Tania! 😊
Tania and Peter have embarked on a journey that has already had such an incredible impact on so many lives. This is already a major win for mental health.
So interesting!
Tania and her husband Peter are real pioneers. Their tenacity, determination and love of humanity were essential ingredients for their success with the TGA. This sacred, ancient, mind medicine was given to us by Nature and helps people heal at the most fundamental level. It has been used for thousands of years and is finally having its comeback. 60-80% success rate is astounding. Modern antidepressants have an extremely low success rate, similar to placebo. Exercise for depression is a much more successful treatment, and I am pleased to hear that Tania mentions changes to diet, lifestyle and exercise as being important and helpful. Just think how many millions of families across the world can be helped by Medicinal Mushrooms. It's time for change. Thank you for this amazing interview and congratulations to Mind Medicine Australia!
Curious why the focus on Australia when Canada’s SAP crossed the finish line first, not to mention Switzerland before them? I know you’ve given the nod to the Swiss in mentions in other episodes, but I do think Canada’s SAP is a bit of an unsung hero! Fraction of the cost of Australia’s scheme. As someone who oversaw shipments of MDMA all over the world for research. Perhaps I missed an episode!
I’m listening, Tim! Thanks for this article. I’ve come to count on your podcast to introduce me to topics I might never have discovered otherwise. I really appreciate all you do.
Hi, Hailey – Thank you for the question. Canada and Switzerland did some wonderful work, in that their governing bodies allowed for certain psychoactive drugs to be used on a case-by-case basis for medical interventions. However, the drugs remained scheduled as restricted drugs/narcotics. Australia was the first country to get them rescheduled and to officially recognize MDMA and psilocybin as medicines for certain psychiatric conditions, rather than merely allowing them to be used as exceptions, while classifying them as prohibited drugs. That's not to diminish what Canada and Switzerland accomplished, only to point out the distinction, while recognizing Australia's incredible achievement. Best, Team Tim Ferriss